Abstract During a 3-year period, 848 patients were detected as carriers of methicillin-resistant Staphylococcus aureus (MRSA) by the Xpert MRSA assay (Cepheid). Among them, 108 patients (12.7 %) were colonized with strains showing methicillin-susceptible phenotypes and absence of the mecA gene, despite being positive with the rapid polymerase chain reaction (PCR) assay. DNA sequences of the staphylococcal cassette chromosome mec (SCCmec) insertion site of these "false-positive" strains was determined by direct sequencing of the genomic DNA. More than half (53.7 %) of the strains had DNA sequences unrelated to either SCC or SCCmec and one-third had DNA sequences related to non-mec SCC. Only 10.2 % of the strains carried sequences related to SCCmec, suggesting that a sequence containing the mecA gene was lost from an SCCmec. These findings differ from the general idea that all methicillin-susceptible S. aureus having positive Xpert MRSA assay results are essentially MRSA that lost the mecA gene.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the leading causes of hospital-acquired infections and is associated with a high mortality rate. Patients with MRSA infections have prolonged length of stay in hospitals, which results in higher costs of hospitalization [1] [2] [3] [4] . With this perspective, surveillance programs play an important role in preventing onward transmission from carriers, resulting in a decreased risk of infection for other patients and reduced economic impact for the hospital. Over the last decade, standard culture techniques have been replaced by more rapid molecular methods to detect MRSA in clinical samples.
Broad-spectrum resistance to β-lactam antibiotics is encoded by the mecA gene, which is located on the staphylococcal cassette chromosome mec (SCCmec), a genomic island inserted at the 3′ end of the rlmH gene (previously named orfX) [5] . Several commercially available polymerase chain reaction (PCR)-based kits detect the junction formed upon the insertion of SCCmec in the chromosome, using primers located in the conserved rlmH gene and several primers and probes detecting different SCCmec types. This rapid detection of MRSA-positive samples within a few hours might have an important impact on MRSA surveillance [6, 7] . However, since their introduction as tools for surveillance and diagnosis, a number of studies have shown that misinterpretation can often occur [8] [9] [10] [11] [12] [13] [14] . In a pilot study aiming to detect the chromosome-SCCmec junction by PCR, a false-positive signal was found in 26 strains (4.6 %) in a collection of 569 methicillin-sensitive S. aureus (MSSA) [15] . A more recent study showed that, among 251 Xpert MRSApositive samples obtained during a 1-year period, 23 (9.2 %) were MSSA isolates [16] . Similarly, a 9-month study conducted in our hospital showed that, among 217 patients with a positive Xpert MRSA assay, 28 (12.9 %) were colonized by an MSSA isolate [8] .
In this study, we characterized the SCCmec insertion site in 108 strains misidentified as MRSA by the Xpert MRSA assay (GeneXpert system, Cepheid, Sunnyvale, CA) during a 3-year period using direct sequencing of genomic DNA.
Materials and methods

Bacterial strains
The University Hospital of Lausanne is a 1,000-bed tertiary care hospital where active surveillance cultures are part of its MRSA control program. The rapid PCR-based Xpert MRSA assay was introduced in June 2009 for MRSA screening. The detection and sampling methods have been described previously [17] . When a discrepant result was obtained, i.e., positive Xpert MRSA assay and absence of typical pink colonies on MRSASelect agar plates (Bio-Rad, Marnes-la-Coquette, France), the strain was tested on a chromogenic S. aureus agar plate (SAID, bioMérieux, Marcy-l′Etoile, France). If S. aureus characteristic green colonies grew on this plate, an Xpert MRSA assay was performed on the colonies and, if positive, the resistance to methicillin was assessed by an antibiogram using the Kirby-Bauer method with cefoxitin (30 μg) and oxacillin (1 μg) disks. Absence of the mecA gene was confirmed by PCR with a previously described method [18] . The presence of ccrAB genes was detected by M-PCR1 (as described by Kondo et al. [18] ). Genotyping of all strains was performed by multilocus sequence typing (MLST) and double-locus sequence typing (DLST), as previously described [19] [20] [21] .
Genomic DNA extraction Genomic DNA was extracted using a protocol described previously [22] . In brief, 3 mL of an overnight culture were centrifuged and resuspended in 50 μL of lysostaphin solution (10 mM Tris-Cl, pH 7.5, and 1 mM EDTA, supplemented with lysostaphin at a final concentration of 0.5 μg/mL). After 30 min of incubation at 37°C, 300 μL of "Nuclei Lysis Solution" (Promega Corporation, Madison, WI) were added and the cell suspensions were heated at 80°C for at least 10 min. The samples were then cooled at room temperature and treated with RNase. Subsequently, 100 μL of "Protein Precipitation Solution" (Promega Corporation) were added to the samples, which were then incubated for 5 min on ice. After centrifugation (4°C, 15,600×g), supernatants were discarded and 300 μL of isopropanol were used to precipitate the DNA, which was then washed with 70 % ethanol and pelleted by centrifugation. DNA samples were then air-dried and rediluted at 4°C overnight in 20 μL of nuclease-free H 2 O. DNA concentrations and qualities were determined using an ND-1000 Spectrophotometer (NanoDrop Technologies, Wilmington, DE).
DNA sequencing and data treatment
Highly concentrated DNA was required for the direct sequencing of genomic DNA, between 2 and 3 μg/μL. The sequencing reaction was performed with 2 μL of DNA, using the BigDye Terminator v.1.1 Sequencing Kit (Applied Biosystems, Foster City, CA), following the protocol of the manufacturer. Sequencing was performed using an ABI PRISM 3730 DNA Analyzer (Applied Biosystems). Two primers binding in conserved regions of the rlmH gene were used for genomic sequencing. The seql_fw primer (CGTTTA GGCCCATACACCAAGATAGAC, starting at position +76 of the rlmH gene) was used in the first instance. A second primer, seq2_fw (CGCAGTAACTACGCACTATCATTCAG C, starting at position +357 of the rlmH gene), was used when the sequence obtained with the first primer was too short.
Sequencing data were analyzed by Geneious software v7.0.6 (Biomatters Ltd., Auckland, New Zealand). An average read length of 685 bp was obtained, with an average phred40 (99.99 % base call accuracy) quality of 82.8 %.
Nucleotide sequence accession numbers
The DNA sequences surrounding the SCCmec insertion sites of one representative strain per sequence group have been deposited in GenBank. The accession numbers are as follows: KJ786840 for strain H26280 (Group 1), KJ786841 for strain H21732 (Group 2), KJ786842 for strain H22446 (Group 3), KJ786843 for strain H25130 (Group 4), KJ786844 for strain H22311 (Group 5), KJ786845 for strain H25652 (Group 6), KJ786846 for strain H24478 (Group 7), KJ786847 for strain H24884 (Group 8), KJ786848 for strain H24314 (Group 9), KJ786849 for strain H23280 (Group 10), KJ786850 for strain H27390 (Group 11), KJ786851 for strain H22887 (Group 12), KJ786852 for strain H27608 (Group 13), KJ786853 for strain H26736 (Group 14), KJ786854 for strain H21876 (Group 15), KJ786855 for strain H25653 (Group 16), KJ786856 for strain H25356 (Group 17), and KJ786857 for strain H24924 (Group 18).
Results
Between July 2010 and June 2013, 848 patients had at least one screening sample detected as being positive by the Xpert MRSA assay. Among them, 108 patients (12.7 %) were colonized by S. aureus isolates which did not contain the mecA gene.
Sequences downstream of the rlmH gene were determined by sequencing directly the genomic DNA and aligned to GenBank/EMBL DNA sequences databases using the BLAST program [23] . Table 1 shows the different groups of sequences and their closest matches obtained with BLAST analysis. Eighteen different groups of sequences were found, highlighting the great diversity of the genetic content downstream of the SCCmec insertion site, as previously described [24] . More than half of all sequences (53.7 %) were not related to SCC elements in general (i.e., presence of sequences in which ccr recombinase genes are absent) and SCCmec in particular (i.e., absence of mecA and ccr genes). Thirtyseven percent of the strains belonged to the 15575 type (Group 1, Table 1 ), which is a previously described MSSA associated with a positive Xpert MRSA assay [14, 24] . Even with the absence of an SCC cassette, these strains showed high sequence identity with the 5′ ends of SCCmec types II or IV, thus explaining the positive result of the Xpert MRSA assay [14] . All strains of the 15575 group belonged to the same clonal complex (CC15, Table 1 ), indicating clonal dissemination, rather than the presence of a hypothetical mobile genetic element at this chromosomal site. Four other groups (Groups 2, 4, 5, and 6, Table 1 ) of SCC-unrelated sequences suggested the presence of putative restriction-modification systems, whose presence was previously described in this region of the chromosome [24] . One-third (36) of the isolates was associated to SCCrelated elements. Among them, 18 strains (16.7 %) showed 100 % identity with an SCC element carrying ccrAB1 genes (Table S1 ) and a putative restriction-modification system from strain CMFT535. Eleven strains (10.2 %) carried a DNA segment closely related to a ΨSCC (SCC without ccr genes) from Staphylococcus haemolyticus strain JCSC1435 encoding unknown proteins. The remaining strains in this group were associated to other ΨSCC or parts of an ACME element (Table 1) .
Only 10.2 % of the strains carried sequences that were associated with the presence of SCCmec (Table 1) . Seven strains had the same genotype of local MRSA clones known to carry type IV SCCmec (DLST 3-3, ST 8-IV; DLST 1-52, ST 45-IV; DLST 4-36, ST 125-IV) and had sequences that matched with several type IV SCCmec present in the databases. This was also true for one strain carrying type II SCCmec (DLST 2-23, ST 5-II). Two strains had infrequent genotypes and carried sequences related to type II and type III/V SCCmec, respectively. One strain had 100 % identity sequence with that of SCCmecN1 from S. aureus LG1-053.
The remaining three strains (2.8 %) showed no identity to sequences present in the GenBank/EMBL DNA sequences databases.
Discussion
We characterized the SCCmec insertion site in 108 isolates that were misidentified as MRSA by the Xpert MRSA assay. Our findings indicate that this chromosomal region is highly diverse among isolates. Surprisingly, more than half of the strains were not associated to SCC or SCCmec sequences and one-third carried non-mec SCC-related sequences. Our results suggests that dropout of the mecA gene could have occurred in only 10.2 % of the strains. This observation is in disagreement with the general idea that MSSA which had a positive result with the Xpert MRSA assay are essentially strains that lost the mecA gene.
Although the clonal spread of some STs could account for these false-positive results (Group 1, ST1; Group 8, ST 8), the fact that different DLST types were observed strongly suggest that this dissemination is not solely local.
The genomic structure of SSCs is complex and, despite many recent next-generation sequencing studies on MRSA, we are still not able to have a clear picture of these mobile genetic elements. Moreover, little is known on SCCs that do not contain the mecA gene. Our results suggest that they are genetically diverse and more frequent than previously thought.
In order to improve rapid PCR-based assays for MRSA screening, further studies are needed in order to investigate the diversity, dissemination, and prevalence of such elements. In the meantime, the results from rapid PCR-based tests should be confirmed by conventional culture methods.
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